Clinical Trial Update: Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain [Phase 3]

View source ↗

Summary

Phase 3 trial of SyB P-1501 (Fentanyl HCI) for postoperative pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• SyB P-1501 (Fentanyl HCI)

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: Postoperative Pain | Phase 3 | Status: TERMINATED